ENDRA Life Sciences Inc. Common Stock (NDRA) is a publicly traded Healthcare sector company. As of July 17, 2026, NDRA trades at $5.24 with a market cap of $7.13M and a P/E ratio of -0.58. NDRA moved +0.00% today. Year to date, NDRA is +16.34%; over the trailing twelve months it is -27.11%. Its 52-week range spans $2.90 to $11.96. Analyst consensus is buy with an average price target of $25.00. Rallies surfaces NDRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for NDRA shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $5.24 |
| Market Cap | $7.13M |
| P/E Ratio | -0.58 |
| EPS | $-8.93 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.96 |
| 52-Week Low | $2.90 |
| Volume | 19.36K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-7.03M |
| Gross Margin | 0.00% |
1 analysts cover NDRA: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $25.00.